Trials / Sponsors / Senti Biosciences
Senti Biosciences
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Includi AML/MDS, CD33 Expressing Hematological Malignancies, FLT3 Expressing Hematological Malignancies | Phase 1 | 2024-04-22 |